More about

Fred Hutchinson

News
March 17, 2021
7 min read
Save

‘On-your-toes’ approach to managing infection risk needed as CAR T-cell therapy evolves

‘On-your-toes’ approach to managing infection risk needed as CAR T-cell therapy evolves

Chimeric antigen receptor T-cell therapy employs a patient’s immune system to fight cancer and thereby weakens it, leaving the recipient vulnerable to infection.

News
February 11, 2021
3 min read
Save

Ruxolitinib improves response rate, failure-free survival in chronic GVHD

Ruxolitinib improves response rate, failure-free survival in chronic GVHD

Ruxolitinib appeared more effective than best available therapy for steroid-refractory or steroid-dependent chronic graft-versus-host disease, according to randomized phase 3 study results presented at TCT Meetings Digital Experience.

News
February 08, 2021
6 min read
Save

Oncologists can allay COVID-19 vaccination concerns of patients with cancer, survivors

Oncologists can allay COVID-19 vaccination concerns of patients with cancer, survivors

Oncologists are in a critical position to provide potentially life-saving information about the COVID-19 vaccine to their patients with cancer, experts said.

News
January 07, 2021
4 min read
Save

Declines in prostate cancer screening after 2012 USPSTF guidance vary by race, ethnicity

Declines in prostate cancer screening after 2012 USPSTF guidance vary by race, ethnicity

Prostate cancer screening rates appeared to differ among Black, white, Hispanic and Asian/Pacific Islander men following the 2012 U.S. Preventive Services Task Force recommendation against routine PSA testing, according to study results.

News
January 06, 2021
3 min read
Save

Sitagliptin may prevent acute GVHD after peripheral blood stem cell transplantation

Sitagliptin may prevent acute GVHD after peripheral blood stem cell transplantation

Sitagliptin significantly reduced incidence of acute graft-versus-host disease after myeloablative allogeneic peripheral blood stem cell transplantation, according to phase 2 study results published in The New England Journal of Medicine.

News
December 05, 2020
5 min read
Save

Fauci: COVID-19 can be crushed, ‘but it’s not going to happen in a few months’

Fauci: COVID-19 can be crushed, ‘but it’s not going to happen in a few months’

Despite promising data that have emerged on COVID-19 vaccine candidates, a return to normal “carefree” life is likely years out, according to Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

News
November 19, 2020
46 min listen
Save

Finding Your Own Way with Julie Gralow, MD

Finding Your Own Way with Julie Gralow, MD

Julie Gralow, MD, is a well-respected and internationally renowned breast oncologist. In this episode, Gralow discusses her journey in oncology, the ASCO Global Oncology Task Force and the importance of finding your own way in medicine.

News
November 07, 2020
2 min read
Save

ASH announces four new executive committee members

ASH announces four new executive committee members

ASH announced the election of four new members to its executive committee.

News
August 31, 2020
58 min listen
Save

Global Oncology with Ben Anderson, MD

Global Oncology with Ben Anderson, MD

In this episode, Benjamin O. Anderson, MD, FACS, creator and chair of The Breast Health Global Initiative at Fred Hutchinson Cancer Research Center, shares how his passion for patient care dovetailed into a career in global oncology.

News
August 27, 2020
3 min read
Save

Post-infusion CAR-T costs considerably higher at academic inpatient hospitals

Post-infusion CAR-T costs considerably higher at academic inpatient hospitals

Chimeric antigen receptor T-cell therapy administration cost nearly $33,000 more at academic inpatient hospitals than nonacademic specialty oncology networks, according to study results published in JAMA Network Open.

View more